CY1109956T1 - Στερεα φαρμακευτικη συνθεση περιλαμβανουσα υδροχλωρικη ντονεπεζιλη - Google Patents
Στερεα φαρμακευτικη συνθεση περιλαμβανουσα υδροχλωρικη ντονεπεζιληInfo
- Publication number
- CY1109956T1 CY1109956T1 CY20091100181T CY091100181T CY1109956T1 CY 1109956 T1 CY1109956 T1 CY 1109956T1 CY 20091100181 T CY20091100181 T CY 20091100181T CY 091100181 T CY091100181 T CY 091100181T CY 1109956 T1 CY1109956 T1 CY 1109956T1
- Authority
- CY
- Cyprus
- Prior art keywords
- pharmaceutical composition
- donepezil
- solid pharmaceutical
- hydrochlorine
- composition included
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000007787 solid Substances 0.000 title abstract 2
- ADEBPBSSDYVVLD-UHFFFAOYSA-N donepezil Chemical compound O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 title 2
- 229960003530 donepezil Drugs 0.000 title 1
- 229960003135 donepezil hydrochloride Drugs 0.000 abstract 2
- XWAIAVWHZJNZQQ-UHFFFAOYSA-N donepezil hydrochloride Chemical compound [H+].[Cl-].O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 XWAIAVWHZJNZQQ-UHFFFAOYSA-N 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Glanulating (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Η εφεύρεση αφορά μια στερεή φαρμακευτική σύνθεση περιλαμβάνουσα ένυδρο υδροχλωρική ντονεπεζίλη και μέθοδο για την παρασκευή αυτής. Συγκεκριμένα αφορά μια σύνθεση και μια μέθοδο, όπου η υδροχλωρική ντονεπεζίλη διατηρεί την πολυμορφική μορφή αυτής και συνεπώς είναι πολύ σταθερή έναντι μετατροπής σε άλλες πολυμορφικές μορφές.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004051055 | 2004-10-19 | ||
EP05795965A EP1811957B1 (en) | 2004-10-19 | 2005-10-19 | Solid pharmaceutical composition comprising donepezil hydrochloride |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1109956T1 true CY1109956T1 (el) | 2014-09-10 |
Family
ID=35464350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20091100181T CY1109956T1 (el) | 2004-10-19 | 2009-02-18 | Στερεα φαρμακευτικη συνθεση περιλαμβανουσα υδροχλωρικη ντονεπεζιλη |
Country Status (19)
Country | Link |
---|---|
US (3) | US20090130205A9 (el) |
EP (3) | EP2039349A1 (el) |
JP (1) | JP2008517022A (el) |
AT (1) | ATE415148T1 (el) |
CA (1) | CA2584547C (el) |
CY (1) | CY1109956T1 (el) |
DE (1) | DE602005011326D1 (el) |
DK (1) | DK1811957T3 (el) |
EA (1) | EA012220B1 (el) |
ES (1) | ES2317313T3 (el) |
HR (1) | HRP20090104T3 (el) |
NO (1) | NO20072494L (el) |
PL (1) | PL1811957T3 (el) |
PT (1) | PT1811957E (el) |
RS (1) | RS51271B (el) |
SI (1) | SI1811957T1 (el) |
UA (1) | UA83152C2 (el) |
WO (1) | WO2006045512A1 (el) |
ZA (1) | ZA200704023B (el) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0515803D0 (en) * | 2005-07-30 | 2005-09-07 | Pliva Hrvatska D O O | Intermediate compounds |
DE102005060377A1 (de) | 2005-12-16 | 2007-06-21 | Ratiopharm Gmbh | Pharmazeutische Zusammensetzung enthaltend Donepezilhydrochlorid, Tablette hieraus und Verfahren zu deren Herstellung |
JP2009537538A (ja) * | 2006-05-15 | 2009-10-29 | アカドイア プハルマセウチカルス インコーポレーテッド | ピマバンセリン医薬製剤 |
GB0614586D0 (en) * | 2006-07-22 | 2006-08-30 | Pliva Istrazivacki Inst D O O | Pharmaceutical Formulation |
AU2008207864B2 (en) * | 2007-01-24 | 2013-07-11 | Cook Biotech Incorporated | Biofilm-inhibiting medical products |
GR20070100405A (el) * | 2007-06-26 | 2009-01-20 | Genepharm �.�. | Βελτιωμενες φαρμακοτεχνικες μορφες που περιεχουν αναστολεις της ακετυλοχοληνεστερασης και μεθοδοι παρασκευης αυτων |
DE102007037932A1 (de) * | 2007-08-11 | 2009-02-12 | Alfred E. Tiefenbacher Gmbh & Co.Kg | Donepezilhydrochlorid in amorpher Form enthaltende Tablette |
DE102009041839A1 (de) * | 2009-09-18 | 2011-03-24 | Dolorgiet Gmbh & Co. Kg | Donepezil-haltige Tabletten |
US20100178307A1 (en) * | 2010-01-13 | 2010-07-15 | Jianye Wen | Transdermal anti-dementia active agent formulations and methods for using the same |
EP2366378A1 (en) | 2010-03-01 | 2011-09-21 | Dexcel Pharma Technologies Ltd. | Sustained-release donepezil formulations |
DE102010010998A1 (de) * | 2010-03-10 | 2011-09-15 | Stada Arzneimittel Ag | Feste pharmazeutische Zusammensetzung, umfassend Donepezil-Hydrochlorid der kristallinen polymorphen Form I |
WO2012016708A1 (en) | 2010-08-06 | 2012-02-09 | Ratiopharm Gmbh | Oral dosage form comprising dimebolin and donepezil |
JP6093707B2 (ja) * | 2010-11-30 | 2017-03-08 | ウィスタ ラボラトリーズ リミテッド | 化合物製剤 |
EP2502620A1 (en) | 2011-03-24 | 2012-09-26 | Krka Tovarna Zdravil, D.D., Novo Mesto | Solid pharmaceutical composition comprising donepezil |
US20150216849A1 (en) | 2014-02-04 | 2015-08-06 | Forest Laboratories Holdings Ltd. | Donepezil compositions and methods of treating alzheimers disease |
CN114272219B (zh) * | 2021-12-30 | 2023-11-10 | 江苏豪森药业集团有限公司 | 一种盐酸多奈哌齐片及其制备方法 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8813064D0 (en) * | 1988-06-02 | 1988-07-06 | Euro Celtique Sa | Controlled release dosage forms having defined water content |
US4956182A (en) * | 1989-03-16 | 1990-09-11 | Bristol-Myers Company | Direct compression cholestyramine tablet and solvent-free coating therefor |
US5698224A (en) * | 1994-06-27 | 1997-12-16 | Alza Corporation | Tacrine therapy |
SK285312B6 (sk) | 1996-06-07 | 2006-10-05 | Eisai Co., Ltd. | Polymorf (III) donepezil hydrochloridu, spôsob jeho výroby a terapeutický prostriedok s jeho obsahom |
JPH1053576A (ja) * | 1996-06-07 | 1998-02-24 | Eisai Co Ltd | 塩酸ドネペジルの多形結晶およびその製造法 |
AU1153097A (en) * | 1996-06-07 | 1998-01-05 | Eisai Co. Ltd. | Stable polymorphs of donepezil (1-benzyl-4-{(5,6-dimethoxy-1-indanon)-2-yl}methylpiperidine ) hydrochloride and process for production |
TW513409B (en) * | 1996-06-07 | 2002-12-11 | Eisai Co Ltd | Polymorphs of donepezil hydrochloride |
AU755062B2 (en) * | 1997-02-07 | 2002-12-05 | Princeton University | Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
US20030077227A1 (en) * | 1997-10-01 | 2003-04-24 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
US6066339A (en) * | 1997-10-17 | 2000-05-23 | Elan Corporation, Plc | Oral morphine multiparticulate formulation |
CN1195862C (zh) * | 1998-02-19 | 2005-04-06 | 札幌啤酒株式会社 | 分离和纯化的包括在蛇麻腺中特异性表达的基因的核酸 |
ATE254928T1 (de) * | 1999-03-31 | 2003-12-15 | Eisai Co Ltd | Stabilisierte zusammensetzung mit nootropen wirkstoffen |
US20030180352A1 (en) * | 1999-11-23 | 2003-09-25 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
PT1260215E (pt) * | 2000-03-01 | 2009-09-03 | Eisai R&D Man Co Ltd | Comprimido de desintegração rápida que contém poli(álcool vinílico) |
US20030022921A1 (en) * | 2001-02-21 | 2003-01-30 | Minutza Leibovici | Stable pharmaceutical formulation comprising torsemide modification II |
IN192180B (el) * | 2001-09-28 | 2004-03-06 | Ranbaxy Lab | |
TWI231760B (en) * | 2001-12-20 | 2005-05-01 | Chugai Pharmaceutical Co Ltd | Coated lozenge and manufacturing method thereof |
SI21223A (sl) * | 2002-06-19 | 2003-12-31 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Farmacevtska formulacija s stabiliziranim amorfnim donepezilijevim kloridom |
IL150509A (en) | 2002-07-01 | 2007-07-04 | Joseph Kaspi | Pharmaceutical preparations containing donafazil hydrochloride |
WO2004047793A1 (en) * | 2002-11-26 | 2004-06-10 | Alk-Abelló A/S | Pharmaceutical allergen product |
AU2003245029A1 (en) * | 2003-04-16 | 2004-11-04 | Hetero Drugs Limited | Novel crystalline forms of donepezil hydrochloride |
US20040265375A1 (en) | 2003-04-16 | 2004-12-30 | Platteeuw Johannes J. | Orally disintegrating tablets |
US20040265372A1 (en) * | 2003-06-27 | 2004-12-30 | David Wynn | Soft tablet containing high molecular weight cellulosics |
-
2005
- 2005-10-19 ES ES05795965T patent/ES2317313T3/es active Active
- 2005-10-19 CA CA2584547A patent/CA2584547C/en not_active Expired - Fee Related
- 2005-10-19 WO PCT/EP2005/011249 patent/WO2006045512A1/en active Application Filing
- 2005-10-19 RS RSP-2009/0048A patent/RS51271B/sr unknown
- 2005-10-19 US US11/577,414 patent/US20090130205A9/en not_active Abandoned
- 2005-10-19 PT PT05795965T patent/PT1811957E/pt unknown
- 2005-10-19 DK DK05795965T patent/DK1811957T3/da active
- 2005-10-19 EA EA200700673A patent/EA012220B1/ru not_active IP Right Cessation
- 2005-10-19 AT AT05795965T patent/ATE415148T1/de active
- 2005-10-19 EP EP08020395A patent/EP2039349A1/en not_active Withdrawn
- 2005-10-19 SI SI200530575T patent/SI1811957T1/sl unknown
- 2005-10-19 EP EP05795965A patent/EP1811957B1/en not_active Revoked
- 2005-10-19 JP JP2007537202A patent/JP2008517022A/ja active Pending
- 2005-10-19 EP EP10176222A patent/EP2283811A1/en not_active Withdrawn
- 2005-10-19 PL PL05795965T patent/PL1811957T3/pl unknown
- 2005-10-19 UA UAA200704303A patent/UA83152C2/ru unknown
- 2005-10-19 DE DE602005011326T patent/DE602005011326D1/de active Active
-
2007
- 2007-05-15 NO NO20072494A patent/NO20072494L/no not_active Application Discontinuation
- 2007-05-18 ZA ZA2007/04023A patent/ZA200704023B/en unknown
-
2009
- 2009-02-18 CY CY20091100181T patent/CY1109956T1/el unknown
- 2009-02-19 HR HR20090104T patent/HRP20090104T3/xx unknown
-
2010
- 2010-01-20 US US12/690,498 patent/US20100317694A1/en not_active Abandoned
-
2012
- 2012-01-10 US US13/346,931 patent/US20120283291A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2039349A1 (en) | 2009-03-25 |
US20120283291A1 (en) | 2012-11-08 |
PL1811957T3 (pl) | 2009-05-29 |
WO2006045512A1 (en) | 2006-05-04 |
DE602005011326D1 (de) | 2009-01-08 |
EP1811957B1 (en) | 2008-11-26 |
US20090130205A9 (en) | 2009-05-21 |
ES2317313T3 (es) | 2009-04-16 |
EP2283811A1 (en) | 2011-02-16 |
PT1811957E (pt) | 2009-01-27 |
UA83152C2 (ru) | 2008-06-10 |
DK1811957T3 (da) | 2009-03-30 |
EP1811957A1 (en) | 2007-08-01 |
NO20072494L (no) | 2007-07-02 |
SI1811957T1 (sl) | 2009-04-30 |
CA2584547C (en) | 2014-07-08 |
ATE415148T1 (de) | 2008-12-15 |
US20080063705A1 (en) | 2008-03-13 |
EA200700673A1 (ru) | 2007-10-26 |
JP2008517022A (ja) | 2008-05-22 |
CA2584547A1 (en) | 2006-05-04 |
HRP20090104T3 (en) | 2009-03-31 |
ZA200704023B (en) | 2008-04-30 |
US20100317694A1 (en) | 2010-12-16 |
RS51271B (sr) | 2010-12-31 |
EA012220B1 (ru) | 2009-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1109956T1 (el) | Στερεα φαρμακευτικη συνθεση περιλαμβανουσα υδροχλωρικη ντονεπεζιλη | |
FR22C1008I2 (fr) | Composition immunogène | |
NO20055686L (no) | Sammensetning, fremgangsmate til fremstilling derav, og anvendelse derav. | |
NO2014009I2 (no) | Forbindelser, farmasøytiske sammensetninger og anvendelser derav, samt fremgangsmåte for å fremstille nevnte forbindelser | |
NO20054329D0 (no) | Adamantanderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger som innbefatter slike | |
DK1711494T3 (da) | Arylsubstituerede heterocykler, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel | |
IS8136A (is) | N-pýrrólidín-3-ýl-amíð afleiður sem serótónín og noradrenalín endurupptöku hindrar | |
DK3090748T3 (da) | Sammensætninger, der omfatter nukleotid- og oligonukleotid-prodrugs | |
DK2444806T3 (da) | Haptener, haptenkonjugater, sammensætninger deraf og fremgangsmåde til deres fremstilling og anvendelse | |
BRPI0618904A2 (pt) | composto, composição farmacêutica, e, uso do composto | |
NO20053569D0 (no) | Substituerte 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazinderivater og deres anvendelse som nevrokininantagonister | |
DK2044076T3 (da) | Fremgangsmåde til fremstilling af asenapin og intermediatprodukter, som anvendes i fremgangsmåden | |
NO20054876D0 (no) | Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikament og medikament inneholdende slike forbindelser | |
IS7980A (is) | Díarýlmetýlídenpíperidínafleiður, framleiðsla þeirra og notkun | |
DK1587478T3 (da) | Farmaceutisk sammensætning | |
BRPI0614413A2 (pt) | composto, e, composição farmacêutica | |
DK1611115T3 (da) | Benzothiazolderivatforbindelser, sammensætninger og anvendelser deraf | |
DK1600207T3 (da) | Emulgator, fremgangsmåde til fremstilling deraf og emulgeret sammensætning der anvender emulgatoren | |
DK1778265T3 (da) | Guanylhydrazoneforbindelser, sammensætninger, fremgangsmåder og anvendelse | |
NO20053598L (no) | Substituerte 1-piperidin-3-yl-4-pyrrolidin-4-yl-piperazinderivater og deres anvendelse som nevrokininantagonister. | |
DK1816121T3 (da) | 9-chlor-15-deoxyprostaglandinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som medikamenter | |
DK1906921T3 (da) | Klar farmaceutisk, vandig mikroemulsion omfattende propofol og fremgangsmåde til fremstilling | |
DK1931304T3 (da) | Hidtil ukendt anvendelse til en sammensætning, der omfatter chlorprocain-HCl, en hidtil ukendt sammensætning, der omfatter chlorprocain-HCl og en fremgangsmåde til fremstilling deraf | |
ITMI20040943A1 (it) | Composizione farmaceutica cicatrizzante | |
ITRM20070222A1 (it) | Derivati 1,3,4 tiadiazolici metodi di preparazione e uso di essi |